UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019638
Receipt number R000022697
Scientific Title The effect of glucose control by artificial endocrine pancreas during hepatectomy on postoperative AKI
Date of disclosure of the study information 2015/12/01
Last modified on 2019/07/25 19:56:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of glucose control by artificial endocrine pancreas during hepatectomy on postoperative AKI

Acronym

GAPAK

Scientific Title

The effect of glucose control by artificial endocrine pancreas during hepatectomy on postoperative AKI

Scientific Title:Acronym

GAPAK

Region

Japan


Condition

Condition

acute kidney injury

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the usefulness of the closed-loop system, a type of artificial endocrine pancreas for continuous monitoring and control of intraoperative blood glucose for preventing postoperative AKI in patients undergoing hepatectomy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

postoperative AKI

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

artificial endocrine pancreas for continuous monitoring and control of intraoperative blood glucose in patients undergoing hepatectomy

Interventions/Control_2

controll glucose level with a manual injection of insulin based on a commonly used sliding scale

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

ASA PS 1-3
patients undergoing hepatectomy

Key exclusion criteria

patients need hemodialysis

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Naoji
Middle name
Last name Mita

Organization

Tokushima University Hospital

Division name

Anesthesiology

Zip code

770-8503

Address

2-50-1, Kuramoto-tyo, Tokushima, Japan

TEL

088-633-7181

Email

mita@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Naoji
Middle name
Last name Mita

Organization

Tokushima University Hospital

Division name

Anesthesiology

Zip code

770-8503

Address

2-50-1, Kuramoto-tyo, Tokushima, Japan

TEL

088-633-7181

Homepage URL


Email

mita@tokushima-u.ac.jp


Sponsor or person

Institute

Tokushima University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board,Tokushima University Hospital

Address

2-50-1, Kuramoto-tyo, Tokushima, Japan

Tel

088-633-9294

Email

first-ec@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

38

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 11 Month 05 Day

Date of IRB

2016 Year 01 Month 05 Day

Anticipated trial start date

2015 Year 12 Month 01 Day

Last follow-up date

2019 Year 05 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 05 Day

Last modified on

2019 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022697


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name